Lifebit is democratising bioinformatics and biomedical data analysis. The company’s platform, Lifebit CloudOS, is fast becoming the industry’s standard for unified and secure research over distributed big data like biobanks. Its innovative engineering, in particular its inherent ‘federated-by-design’ architecture, is solving the major problems and hurdles faced by pharmaceutical and biotechnology organisations the world over. As biobanks today present a growing wealth of data opportunities waiting to be tapped, Lifebit’s technology shows us what is possible. Deployed directly in clients’ own AWS, all data remains within their secure environments without ever leaving - a novel concept, where compute is brought to the data and not the other way around. This federated technology lends itself ideally to organisations’ missions to safeguard biobank participants’ and clients’ data security.
Pharmaceutical companies can now easily leverage biobank data and now EVERYONE can have this weapons grade platform in their own AWS environment. Users of this platform may be novice or advanced; we take a look at typical user journeys and key platform capabilities, including data security and federation, and advanced UX/UI design that allows all researchers to easily utilise data and arrive at insights faster. We dive deeper to explore the platform’s integration to all open-source analysis and visualisation tools, as well as a marketplace of proprietary ones, powerful data and cohort browser, and advanced AI functionality. What does this all mean for life sciences, precision medicine, and for the world? We discuss how this ground-breaking technology is already powering genomics science to enhance lives.
Thorben Seeger, VP Commercial and Filippo Abbondanza, Bioinformatic Solution Architect, Lifebit
